These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12901250)

  • 21. Thrombophilia and outcome in severe infection and sepsis.
    Hofstra JJ; Schouten M; Levi M
    Semin Thromb Hemost; 2007 Sep; 33(6):604-9. PubMed ID: 17768693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology.
    Vincent JL
    Crit Care; 2001; 5(2):S1-5. PubMed ID: 11379985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathophysiology of sepsis--will the basic research contribute to the improvement of outcome in clinical sepsis?].
    Karima R
    Masui; 2008 Mar; 57(3):278-93. PubMed ID: 18340996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activated proteine C].
    Montravers P; Quintard H; Piednoir P
    Ann Fr Anesth Reanim; 2006 Mar; 25(3):270-4. PubMed ID: 16387470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What role do coagulation disorders play in the pathogenesis of leptospirosis?
    Wagenaar JF; Goris MG; Sakundarno MS; Gasem MH; Mairuhu AT; de Kruif MD; Ten Cate H; Hartskeerl R; Brandjes DP; van Gorp EC
    Trop Med Int Health; 2007 Jan; 12(1):111-22. PubMed ID: 17207155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic agents in the treatment of severe sepsis.
    Iqbal O; Messmore H; Fareed J; Ahmad S; Hoppensteadt D; Hazar S; Tobu M; Aziz S; Wehrmacher W
    Expert Opin Emerg Drugs; 2002 May; 7(1):111-39. PubMed ID: 15989540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sepsis diagnosis and management: work in progress.
    Vincent JL; Habib AM; Verdant C; Bruhn A
    Minerva Anestesiol; 2006 Mar; 72(3):87-96. PubMed ID: 16493385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of the endothelium to trauma and sepsis. Adherence, cytokine effects and procoagulatory response.
    Redl H; Schlag G; Kneidinger R; Ohlinger W; Davies J
    Arzneimittelforschung; 1994 Mar; 44(3A):443-6. PubMed ID: 8185720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response.
    Richardson MA; Gupta A; O'Brien LA; Berg DT; Gerlitz B; Syed S; Sharma GR; Cramer MS; Heuer JG; Galbreath EJ; Grinnell BW
    J Pharmacol Exp Ther; 2008 Apr; 325(1):17-26. PubMed ID: 18182560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of inflammation on coagulation and vice versa.
    van der Poll T; de Boer JD; Levi M
    Curr Opin Infect Dis; 2011 Jun; 24(3):273-8. PubMed ID: 21330919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural anticoagulant inhibitors: activated Protein C.
    Aird WC
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):161-82. PubMed ID: 15171965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sepsis-Induced Coagulopathy: A Comprehensive Narrative Review of Pathophysiology, Clinical Presentation, Diagnosis, and Management Strategies.
    Williams B; Zou L; Pittet JF; Chao W
    Anesth Analg; 2024 Apr; 138(4):696-711. PubMed ID: 38324297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute coagulopathy of trauma: mechanism, identification and effect.
    Brohi K; Cohen MJ; Davenport RA
    Curr Opin Crit Care; 2007 Dec; 13(6):680-5. PubMed ID: 17975390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sepsis: infection and systemic inflammatory response].
    Holub M
    Cas Lek Cesk; 2007; 146(2):109-14. PubMed ID: 17373103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coagulation disorders in liver disease.
    Amitrano L; Guardascione MA; Brancaccio V; Balzano A
    Semin Liver Dis; 2002 Feb; 22(1):83-96. PubMed ID: 11928081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of protein C concentrate in adult patients with severe sepsis and septic shock].
    Baratto F; Michielan F; Gagliardi G; Di Gregorio G; Pasqualetto A; Meroni M; Giron GP
    Minerva Anestesiol; 2004 May; 70(5):351-6. PubMed ID: 15181415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sepsis: from pathophysiology to treatment].
    Gesualdo L; Cirillo P; Netti S; Centonze D; Perego AF
    G Ital Nefrol; 2006; 23 Suppl 36():S74-8. PubMed ID: 17068733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood coagulation disorders in septic patients.
    Knoebl P
    Wien Med Wochenschr; 2010 Mar; 160(5-6):129-38. PubMed ID: 20364416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulation dysfunction in sepsis and multiple organ system failure.
    Nimah M; Brilli RJ
    Crit Care Clin; 2003 Jul; 19(3):441-58. PubMed ID: 12848314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.